David A Khan
University of Texas Southwestern Medical Center · Department of Allergy and Immunology, UT Southwestern
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name David A Khan as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 01:55 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT06406114 · Optimizing the Diagnostic Approach to Cephalosporin Allergy TestingMassachusetts General Hospital · recruiting · Drug Allergy, Cephalosporin Allergy, Drug Hypersensitivity · principal investigator
- N/ANCT00745849 · Efficacy of Esomeprazole for Non-Allergic Rhinitis: A Double-blind, Placebo Controlled TrialUniversity of Texas Southwestern Medical Center · completed · Vasomotor Rhinitis · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 01:55 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 1 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
- A Selective Serotonin Reuptake Inhibitor for Asthma Patients with Frequent ExacerbationsR33HL167909 · NHLBI · UT SOUTHWESTERN MEDICAL CENTER · fiscal years 2025 to 2026 · $789,365 awarded in 2026Same name and institution; not confirmed by an ID
- Optimizing the diagnostic approach to cephalosporin allergy testing (DACAT Trial)U01AI184071 · NIAID · MAYO CLINIC JACKSONVILLE · fiscal years 2024 to 2026 · $2,832,926 awarded in 2026Grant number is on one of their registry trials
- A Selective Serotonin Reuptake Inhibitor for Asthma Patients with Frequent ExacerbationsR61HL167909 · NHLBI · UT SOUTHWESTERN MEDICAL CENTER · fiscal years 2024 · $790,698 awarded in 2024Same name and institution; not confirmed by an ID
- Determining the Accuracy of Cephalosporin Allergy TestingR34AI134569 · NIAID · UT SOUTHWESTERN MEDICAL CENTER · fiscal years 2019 · $292,598 awarded in 2019Same name and institution; not confirmed by an ID
- EFFICACY OF DAPSONE IN CHRONIC IDIOPATHIC URTICARIAM01RR000633 · NCRR · UT SOUTHWESTERN MEDICAL CENTER · fiscal years 1999 to 2005 · $3,538 awarded in 2005Same name and institution; not confirmed by an ID
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 01:55 UTC. The ranking covers the 200 most relevant of 27 PubMed records, and a shared surname and initials can bring in a namesake. All 27 on PubMed
- Hippocampal volume, spectroscopy, cognition, and mood in patients receiving corticosteroid therapy.Biol Psychiatry · 2004206 citationsRCR 5.8
- Role of resveratrol supplementation in regulation of glucose hemostasis, inflammation and oxidative stress in patients with diabetes mellitus type 2: A randomized, placebo-controlled trial.Complement Ther Med · 2022113 citationsRCR 12.1
- A randomized trial of citalopram versus placebo in outpatients with asthma and major depressive disorder: a proof of concept study.Biol Psychiatry · 200579 citationsRCR 2.5
- A Randomized, Double-Blind, Placebo-Controlled Trial of Escitalopram in Patients with Asthma and Major Depressive Disorder.J Allergy Clin Immunol Pract · 201849 citationsRCR 2.5
- Effects of Delta-tocotrienol Supplementation on Liver Enzymes, Inflammation, Oxidative stress and Hepatic Steatosis in Patients with Nonalcoholic Fatty Liver Disease.Turk J Gastroenterol · 201842 citationsRCR 2.3
- Double-blind placebo-controlled trial of dapsone in antihistamine refractory chronic idiopathic urticaria.J Allergy Clin Immunol Pract · 201441 citationsRCR 1.9
- Repeat treatment of acute hereditary angioedema attacks with open-label icatibant in the FAST-1 trial.Clin Exp Immunol · 201439 citationsRCR 1.8
- The Quick Inventory of Depressive Symptomatology-Self-report: a psychometric evaluation in patients with asthma and major depressive disorder.Ann Allergy Asthma Immunol · 200838 citationsRCR 1.2
- Delta-tocotrienol supplementation improves biochemical markers of hepatocellular injury and steatosis in patients with nonalcoholic fatty liver disease: A randomized, placebo-controlled trial.Complement Ther Med · 202034 citationsRCR 2.1
- Escitalopram for severe asthma and major depressive disorder: a randomized, double-blind, placebo-controlled proof-of-concept study.Psychosomatics · 201226 citationsRCR 1.0